Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 8 | 2013 | 1185 | 0.880 |
Why?
|
Anxiety | 2 | 2011 | 308 | 0.650 |
Why?
|
Depression | 2 | 2013 | 505 | 0.610 |
Why?
|
Social Support | 2 | 2013 | 209 | 0.460 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 166 | 0.460 |
Why?
|
Biotinylation | 1 | 2012 | 42 | 0.430 |
Why?
|
Self Efficacy | 1 | 2013 | 55 | 0.420 |
Why?
|
Depressive Disorder | 2 | 2013 | 221 | 0.420 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 92 | 0.410 |
Why?
|
Plasmids | 1 | 2012 | 291 | 0.400 |
Why?
|
Health Status | 2 | 2011 | 371 | 0.400 |
Why?
|
Simplexvirus | 1 | 2012 | 151 | 0.390 |
Why?
|
Patient Compliance | 1 | 2013 | 231 | 0.390 |
Why?
|
Activities of Daily Living | 1 | 2011 | 207 | 0.350 |
Why?
|
Stress, Psychological | 1 | 2011 | 322 | 0.310 |
Why?
|
Quality of Life | 2 | 2011 | 1668 | 0.260 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 172 | 0.220 |
Why?
|
Immediate-Early Proteins | 2 | 2016 | 165 | 0.220 |
Why?
|
Heart Transplantation | 3 | 2005 | 717 | 0.210 |
Why?
|
Coronary Disease | 9 | 1994 | 260 | 0.190 |
Why?
|
Patient Selection | 1 | 2005 | 684 | 0.190 |
Why?
|
Myocardial Ischemia | 2 | 2005 | 162 | 0.180 |
Why?
|
Angioplasty, Balloon, Laser-Assisted | 2 | 1996 | 2 | 0.170 |
Why?
|
Middle Aged | 30 | 2013 | 25974 | 0.150 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2016 | 3 | 0.140 |
Why?
|
Promyelocytic Leukemia Protein | 1 | 2016 | 8 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2005 | 353 | 0.130 |
Why?
|
Male | 34 | 2013 | 42410 | 0.120 |
Why?
|
Immunity, Innate | 1 | 2018 | 430 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2015 | 49 | 0.120 |
Why?
|
Virus Replication | 1 | 2016 | 324 | 0.120 |
Why?
|
Humans | 50 | 2018 | 89349 | 0.110 |
Why?
|
Surveys and Questionnaires | 2 | 2013 | 2623 | 0.110 |
Why?
|
Herpesvirus 1, Human | 1 | 2016 | 244 | 0.110 |
Why?
|
Coronary Vasospasm | 2 | 1992 | 8 | 0.110 |
Why?
|
Aged | 18 | 2013 | 19165 | 0.110 |
Why?
|
Genes, Viral | 1 | 2012 | 117 | 0.110 |
Why?
|
Female | 26 | 2013 | 46200 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 136 | 0.100 |
Why?
|
Adult | 23 | 2013 | 26607 | 0.100 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 64 | 0.100 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 106 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 104 | 0.100 |
Why?
|
DNA, Complementary | 1 | 2012 | 392 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2018 | 1223 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 277 | 0.100 |
Why?
|
Self Care | 1 | 2013 | 165 | 0.100 |
Why?
|
Florida | 2 | 2011 | 57 | 0.100 |
Why?
|
HeLa Cells | 1 | 2012 | 511 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 428 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 1993 | 374 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 54 | 0.090 |
Why?
|
Personality Inventory | 1 | 2011 | 109 | 0.090 |
Why?
|
Self Concept | 1 | 2011 | 133 | 0.090 |
Why?
|
Risk Factors | 4 | 2011 | 5498 | 0.090 |
Why?
|
MicroRNAs | 1 | 2015 | 551 | 0.090 |
Why?
|
Escherichia coli | 1 | 2012 | 605 | 0.090 |
Why?
|
Self Report | 1 | 2011 | 297 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 956 | 0.080 |
Why?
|
Medication Adherence | 1 | 2011 | 140 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 866 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 1993 | 605 | 0.080 |
Why?
|
Coronary Thrombosis | 1 | 1989 | 14 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2005 | 98 | 0.080 |
Why?
|
Emotions | 1 | 2011 | 349 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2011 | 1072 | 0.070 |
Why?
|
Heart Ventricles | 10 | 2005 | 779 | 0.070 |
Why?
|
Prevalence | 1 | 2011 | 1243 | 0.070 |
Why?
|
Coronary Angiography | 7 | 2003 | 242 | 0.070 |
Why?
|
Electrocardiography | 15 | 1992 | 494 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2011 | 8241 | 0.070 |
Why?
|
Sick Sinus Syndrome | 1 | 2005 | 9 | 0.060 |
Why?
|
Cardiac Output | 3 | 2005 | 156 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2005 | 101 | 0.060 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2005 | 113 | 0.060 |
Why?
|
Serum Albumin | 1 | 2005 | 127 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2005 | 89 | 0.060 |
Why?
|
Oxygen Consumption | 2 | 2005 | 244 | 0.060 |
Why?
|
Survival Analysis | 2 | 2005 | 1534 | 0.060 |
Why?
|
Creatinine | 1 | 2005 | 293 | 0.060 |
Why?
|
Home Care Services | 1 | 2005 | 73 | 0.060 |
Why?
|
Waiting Lists | 1 | 2005 | 184 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2003 | 22 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2003 | 39 | 0.060 |
Why?
|
Leg | 1 | 2003 | 140 | 0.050 |
Why?
|
Heart Conduction System | 6 | 1978 | 112 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2003 | 106 | 0.050 |
Why?
|
Heart Arrest | 4 | 1991 | 279 | 0.050 |
Why?
|
Acute Disease | 4 | 2005 | 841 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 1994 | 66 | 0.050 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2001 | 3 | 0.050 |
Why?
|
Holmium | 3 | 1996 | 3 | 0.050 |
Why?
|
Sirolimus | 1 | 2002 | 170 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 4 | 1992 | 199 | 0.050 |
Why?
|
Tacrolimus | 1 | 2002 | 369 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2005 | 347 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 1723 | 0.040 |
Why?
|
Brain Diseases | 1 | 2001 | 186 | 0.040 |
Why?
|
Neoplasms | 1 | 2015 | 3041 | 0.040 |
Why?
|
Chromosomal Instability | 1 | 2018 | 19 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2005 | 1840 | 0.040 |
Why?
|
Mice | 3 | 2018 | 11761 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2003 | 475 | 0.040 |
Why?
|
Statistics as Topic | 3 | 2011 | 234 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 2 | 1992 | 41 | 0.040 |
Why?
|
Biomarkers | 1 | 2005 | 1767 | 0.040 |
Why?
|
Cohort Studies | 1 | 2005 | 2869 | 0.040 |
Why?
|
Prognosis | 2 | 2005 | 3783 | 0.040 |
Why?
|
Heart | 6 | 1989 | 573 | 0.040 |
Why?
|
Graft Rejection | 1 | 2002 | 1070 | 0.030 |
Why?
|
Homeostasis | 1 | 2018 | 417 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2016 | 25 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2016 | 24 | 0.030 |
Why?
|
Vero Cells | 1 | 2016 | 103 | 0.030 |
Why?
|
Adolescent | 6 | 2005 | 9263 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2016 | 122 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 126 | 0.030 |
Why?
|
Autoantigens | 1 | 2016 | 129 | 0.030 |
Why?
|
Tachycardia | 5 | 1980 | 37 | 0.030 |
Why?
|
Bioprosthesis | 2 | 1986 | 39 | 0.030 |
Why?
|
Heterografts | 1 | 2015 | 102 | 0.030 |
Why?
|
Heart Valve Prosthesis | 2 | 1986 | 98 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 195 | 0.030 |
Why?
|
Mice, SCID | 1 | 2015 | 261 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 313 | 0.030 |
Why?
|
Time Factors | 7 | 2005 | 5337 | 0.030 |
Why?
|
Diastole | 1 | 1993 | 141 | 0.030 |
Why?
|
Hemodynamics | 6 | 1989 | 731 | 0.030 |
Why?
|
Animals | 3 | 2018 | 27369 | 0.030 |
Why?
|
Angioplasty, Balloon | 1 | 1993 | 96 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2018 | 1652 | 0.030 |
Why?
|
Bundle of His | 5 | 1978 | 46 | 0.020 |
Why?
|
Laser Therapy | 1 | 1993 | 149 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2016 | 726 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2011 | 2758 | 0.020 |
Why?
|
Hostility | 1 | 2011 | 25 | 0.020 |
Why?
|
Gene Expression | 1 | 2015 | 1310 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 1109 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2003 | 6811 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 590 | 0.020 |
Why?
|
Psychometrics | 1 | 2011 | 330 | 0.020 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 1989 | 7 | 0.020 |
Why?
|
Angina Pectoris, Variant | 1 | 1989 | 1 | 0.020 |
Why?
|
Heart Rupture | 1 | 1989 | 9 | 0.020 |
Why?
|
Pacemaker, Artificial | 4 | 1977 | 95 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 2558 | 0.020 |
Why?
|
Ventricular Fibrillation | 3 | 1980 | 68 | 0.020 |
Why?
|
Phenotype | 1 | 2015 | 2440 | 0.020 |
Why?
|
Wolff-Parkinson-White Syndrome | 2 | 1977 | 11 | 0.020 |
Why?
|
Comorbidity | 1 | 2011 | 949 | 0.020 |
Why?
|
Physical Exertion | 1 | 1986 | 38 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 415 | 0.020 |
Why?
|
Cardiac Catheterization | 6 | 1989 | 303 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1986 | 111 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 1986 | 132 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 1714 | 0.020 |
Why?
|
Bundle-Branch Block | 4 | 1978 | 55 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2003 | 3666 | 0.020 |
Why?
|
Resuscitation | 2 | 1989 | 109 | 0.020 |
Why?
|
Myocardial Revascularization | 2 | 1975 | 30 | 0.020 |
Why?
|
Propranolol | 2 | 1982 | 44 | 0.010 |
Why?
|
Heart Atria | 5 | 1977 | 282 | 0.010 |
Why?
|
Plethysmography | 1 | 2003 | 18 | 0.010 |
Why?
|
Compliance | 1 | 2003 | 21 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2002 | 784 | 0.010 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2003 | 71 | 0.010 |
Why?
|
Oxyhemoglobins | 2 | 1980 | 30 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 1975 | 234 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 180 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2003 | 2284 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1984 | 319 | 0.010 |
Why?
|
Verapamil | 1 | 1982 | 34 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2003 | 106 | 0.010 |
Why?
|
Cause of Death | 1 | 2003 | 269 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 233 | 0.010 |
Why?
|
Phialophora | 1 | 2001 | 1 | 0.010 |
Why?
|
Thoracic Injuries | 1 | 1981 | 38 | 0.010 |
Why?
|
Immunocompetence | 1 | 2001 | 26 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1981 | 92 | 0.010 |
Why?
|
Heart Block | 2 | 1978 | 31 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 2 | 1977 | 7 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 781 | 0.010 |
Why?
|
Mycoses | 1 | 2001 | 46 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2015 | 3011 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2003 | 387 | 0.010 |
Why?
|
Stroke Volume | 1 | 2003 | 463 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2003 | 988 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 1489 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1981 | 113 | 0.010 |
Why?
|
Diatrizoate | 1 | 1980 | 11 | 0.010 |
Why?
|
Atrial Fibrillation | 2 | 1992 | 358 | 0.010 |
Why?
|
Atrioventricular Node | 2 | 1978 | 35 | 0.010 |
Why?
|
Diatrizoate Meglumine | 1 | 1980 | 19 | 0.010 |
Why?
|
Emergencies | 1 | 1980 | 121 | 0.010 |
Why?
|
Incidence | 1 | 2003 | 1595 | 0.010 |
Why?
|
Unconsciousness | 1 | 1977 | 4 | 0.010 |
Why?
|
Atrial Flutter | 1 | 1977 | 36 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1977 | 65 | 0.010 |
Why?
|
Tinnitus | 1 | 1977 | 21 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1976 | 42 | 0.010 |
Why?
|
Sinoatrial Node | 1 | 1976 | 12 | 0.010 |
Why?
|
Radiography | 2 | 1994 | 809 | 0.010 |
Why?
|
Myxoma | 1 | 1975 | 30 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2003 | 9057 | 0.010 |
Why?
|
Contrast Media | 1 | 1980 | 1091 | 0.010 |
Why?
|
Heart Septum | 2 | 1989 | 47 | 0.010 |
Why?
|
Heart Neoplasms | 1 | 1975 | 63 | 0.010 |
Why?
|
Angiography | 2 | 1991 | 208 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 360 | 0.010 |
Why?
|
Mitral Valve | 2 | 1986 | 262 | 0.010 |
Why?
|
Ergonovine | 1 | 1992 | 2 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 1992 | 52 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1992 | 121 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 1144 | 0.010 |
Why?
|
Pilot Projects | 1 | 1993 | 871 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1992 | 234 | 0.010 |
Why?
|
Angina Pectoris | 2 | 1982 | 29 | 0.010 |
Why?
|
Registries | 1 | 1994 | 784 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1992 | 363 | 0.010 |
Why?
|
Bradycardia | 2 | 1980 | 40 | 0.000 |
Why?
|
Echocardiography | 2 | 1989 | 938 | 0.000 |
Why?
|
Death, Sudden | 2 | 1980 | 40 | 0.000 |
Why?
|
Coronary Artery Disease | 1 | 1992 | 362 | 0.000 |
Why?
|
Electrophysiology | 2 | 1978 | 403 | 0.000 |
Why?
|
Heart Diseases | 1 | 1989 | 298 | 0.000 |
Why?
|
Endocarditis, Bacterial | 1 | 1986 | 39 | 0.000 |
Why?
|
Thromboembolism | 1 | 1986 | 120 | 0.000 |
Why?
|
Myocardium | 1 | 1989 | 571 | 0.000 |
Why?
|
Risk | 2 | 1977 | 657 | 0.000 |
Why?
|
Angiocardiography | 2 | 1975 | 31 | 0.000 |
Why?
|
Cineangiography | 1 | 1984 | 13 | 0.000 |
Why?
|
Age Factors | 1 | 1989 | 1870 | 0.000 |
Why?
|
Aortic Valve | 1 | 1986 | 244 | 0.000 |
Why?
|
Aortography | 1 | 1984 | 65 | 0.000 |
Why?
|
Child | 2 | 1986 | 7173 | 0.000 |
Why?
|
Prospective Studies | 1 | 1992 | 4289 | 0.000 |
Why?
|
Anticoagulants | 1 | 1986 | 427 | 0.000 |
Why?
|
Hospitalization | 2 | 1980 | 877 | 0.000 |
Why?
|
Equipment Failure | 1 | 1983 | 121 | 0.000 |
Why?
|
Graft Survival | 1 | 1986 | 900 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1983 | 115 | 0.000 |
Why?
|
Calcinosis | 1 | 1983 | 230 | 0.000 |
Why?
|
Reoperation | 1 | 1983 | 599 | 0.000 |
Why?
|
Erythrocyte Membrane | 1 | 1980 | 61 | 0.000 |
Why?
|
Femoral Artery | 1 | 1980 | 83 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1981 | 228 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1980 | 501 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1978 | 270 | 0.000 |
Why?
|
Purkinje Fibers | 1 | 1978 | 27 | 0.000 |
Why?
|
Arrhythmia, Sinus | 1 | 1977 | 7 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1982 | 1941 | 0.000 |
Why?
|
Quinidine | 1 | 1977 | 11 | 0.000 |
Why?
|
Diphosphoglyceric Acids | 1 | 1977 | 10 | 0.000 |
Why?
|
Lidocaine | 1 | 1977 | 65 | 0.000 |
Why?
|
Erythrocytes | 1 | 1977 | 254 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1977 | 187 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1976 | 120 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1977 | 266 | 0.000 |
Why?
|
Myocardial Contraction | 1 | 1977 | 252 | 0.000 |
Why?
|
Mobile Health Units | 1 | 1975 | 11 | 0.000 |
Why?
|
Saphenous Vein | 1 | 1975 | 61 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1975 | 101 | 0.000 |
Why?
|
Oxygen | 1 | 1980 | 743 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1975 | 90 | 0.000 |
Why?
|
Chronic Disease | 1 | 1977 | 950 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1975 | 344 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1975 | 190 | 0.000 |
Why?
|
Blood Pressure | 1 | 1975 | 900 | 0.000 |
Why?
|